August 20, 2014 - ASM Comments to FDA on Rapid Influenza Test Classification
ASM commented on an FDA proposal to reclassify antigen based rapid influenza virus antigen detection test systems intended to detect influenza virus directly from clinical specimens.
ASM Statement on Dual Use Research of Concern and Biosafety
The ASM sent a statement to ASM members on Dual Use Research of Concern and Biosafety.
July 21, 2014 - ASM Letter Regarding the Accelerating Biomedical Research Act
The ASM sent a letter to Senator Tom Harkin thanking him for the Accelerating Biomedical Research Act and his leadership regarding funding for the National Institutes of Health.
July 30, 2014 - Historical Background Related to Select Agents
The ASM has prepared a history related to select agents.
July 14, 2014 - ASM Provides Comments on the Protecting Access to Medicare Act to CMS
ASM provided comments to the Centers for Medicare & Medicaid Services (CMS) regarding Section 1834A, “Improving Policies for Clinical Diagnostic Laboratory Tests,” added to the Social Security Law by the Protecting Access to Medicare Act of 2014 (PAMA).